Currently browsing tag


Novartis hit by China, emerging market slowdown: CEO on CNBC

Drugmaker Novartis has been hit by a slowdown in emerging markets, particularly in China, where previously double-digit growth has decelerated to mid-single digits, Chief Executive Joe Jimenez said in an interview with CNBC on Friday. Jimenez' comments echoed concerns expressed on Thursday by U.S. Federal Reserve Chair Janet Yellen, who said the outlook in emerging markets including China have led to volatility. Despite the increasing risks, Jimenez said the Swiss company was not pulling back from emerging markets, rather relying on the strength of generics in China to drive business growth.

Novartis to start human tests with Google lens in 2016

Novartis plans the first human tests next year of a “smart” contact lens it is developing with Google designed to help restore the eye's natural autofocus. “This project is progressing well,” Novartis Chief Executive Joe Jimenez told Swiss newspaper Le Temps in an interview. “I had said it would take about five years to see a product on the market,” Jimenez told the paper.